Simultaneous EEG/fMRI recorded during ketamine infusion in patients with major depressive disorder.
Adolescent
Adult
Anesthetics, Dissociative
/ administration & dosage
Cross-Over Studies
Depressive Disorder, Major
/ diagnostic imaging
Double-Blind Method
Electroencephalography
/ drug effects
Female
Humans
Infusions, Intravenous
Ketamine
/ administration & dosage
Magnetic Resonance Imaging
/ methods
Male
Middle Aged
Young Adult
Depression
EEG
Ketamine
fMRI
Journal
Progress in neuro-psychopharmacology & biological psychiatry
ISSN: 1878-4216
Titre abrégé: Prog Neuropsychopharmacol Biol Psychiatry
Pays: England
ID NLM: 8211617
Informations de publication
Date de publication:
20 04 2020
20 04 2020
Historique:
received:
15
08
2019
revised:
05
12
2019
accepted:
12
12
2019
pubmed:
18
12
2019
medline:
1
4
2021
entrez:
18
12
2019
Statut:
ppublish
Résumé
A single subanaesthetic dose of ketamine rapidly alleviates the symptoms of major depressive disorder (MDD). However, few studies have investigated the acute effects of ketamine on the BOLD pharmacological magnetic resonance imaging (phMRI) response and EEG spectra. In a randomised, double-blind, active placebo-controlled crossover trial, resting-state simultaneous EEG/fMRI was collected during infusion of ketamine or active placebo (remifentanil) in 30 participants with MDD. Montgomery-Asberg depression rating scale scores showed a significant antidepressant effect of ketamine compared to placebo (69% response rate). phMRI analyses showed BOLD signal increases in the anterior cingulate and medial prefrontal cortices and sensitivity of the decrease in subgenual anterior cingulate cortex (sgACC) BOLD signal to noise correction. EEG spectral analysis showed increased theta, high beta, low and high gamma power, and decreased delta, alpha, and low beta power with differing time-courses. Low beta and high gamma power time courses explained significant variance in the BOLD signal. Interestingly, the variance explained by high gamma power was significantly associated with non-response to ketamine, but significant associations were not found for other neurophysiological markers when noise correction was implemented. The results suggest that the decrease in sgACC BOLD signal is potentially noise and unrelated to ketamine's antidepressant effect, highlighting the importance of noise correction and multiple temporal regressors for phMRI analyses. The lack of effects significantly associated with antidepressant response suggests the phMRI methodology employed was unable to detect such effects, the effect sizes are relatively small, or that other processes, e.g. neural plasticity, underlie ketamine's antidepressant effect.
Identifiants
pubmed: 31843628
pii: S0278-5846(19)30689-X
doi: 10.1016/j.pnpbp.2019.109838
pii:
doi:
Substances chimiques
Anesthetics, Dissociative
0
Ketamine
690G0D6V8H
Types de publication
Journal Article
Randomized Controlled Trial
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
109838Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declaration of Competing Interest The authors declare no potential conflict of interest.